CDT EQUITY INC. Diluted Shares Outstanding (Weighted Average)
CDT EQUITY INC. (CDT) reported Diluted Shares Outstanding (Weighted Average) of 533.00 thousand shares for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-09-08
- CDT EQUITY INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 533.00K shares, a 96633.03% increase year-over-year.
- CDT EQUITY INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 730.46K shares, a 56306.25% increase year-over-year.
- CDT EQUITY INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was -703.43K shares.
- CDT EQUITY INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 540.84K shares, a 7346.51% increase year-over-year.
- CDT EQUITY INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 678.94K shares, a 98.19% decline from fiscal 2022.
- CDT EQUITY INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 37.45M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 533.00K shares S-1 · filed 2026-09-08 | 304.29K shares S-1 · filed 2026-09-08 | 186.68K shares derived: average of 3 quarters · filed 2026-09-08 | 275.22K shares derived: average of 4 quarters · filed 2026-09-08 | ||||
| 2026-03-31 | 730.46K shares 10-Q · filed 2026-07-15 | 13.52K shares derived: average of 2 quarters · filed 2026-09-08 | 189.29K shares derived: average of 3 quarters · filed 2026-09-08 | 142.11K shares derived: average of 4 quarters · filed 2026-09-08 | ||||
| 2025-12-31 | -703.43K shares derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | -81.29K shares derived: average of 2 quarters · filed 2026-09-08 | -54.01K shares derived: average of 3 quarters · filed 2026-09-08 | 3.33K shares S-1 · filed 2026-09-08 | 33.30K shares 10-K · filed 2026-04-15 | |||
| 2025-09-30 | 540.84K shares 10-Q · filed 2025-11-13 | 270.70K shares derived: average of 2 quarters · filed 2026-09-08 | 238.92K shares 10-Q · filed 2025-11-13 | 130.81K shares derived: average of 4 quarters · filed 2026-09-08 | ||||
| 2025-06-30 | 551.00 shares S-1 · filed 2026-09-08 | 1.10M shares 10-Q · filed 2025-08-14 | 342.00 shares S-1 · filed 2026-09-08 | 683.59K shares 10-Q · filed 2025-08-14 | -5.87K shares derived: average of 3 quarters · filed 2026-09-08 | -2.59K shares derived: average of 4 quarters · filed 2026-09-08 | ||
| 2025-03-31 | 1.29K shares 10-Q · filed 2026-07-15 | 3.89M shares 10-Q · filed 2025-05-15 | -9.08K shares derived: average of 2 quarters · filed 2026-09-08 | -3.63K shares derived: average of 3 quarters · filed 2026-09-08 | 9.58K shares derived: average of 4 quarters · filed 2026-09-08 | |||
| 2024-12-31 | -19.46K shares derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | -6.10K shares derived: average of 2 quarters · filed 2026-09-08 | 12.35K shares derived: average of 3 quarters · filed 2026-09-08 | 29.00 shares S-1 · filed 2026-09-08 | 867.10K shares 10-K · filed 2025-03-28 | |||
| 2024-09-30 | 7.26K shares 10-Q · filed 2025-11-13 | 87.16M shares 10-Q · filed 2024-11-14 | 28.25K shares derived: average of 2 quarters · filed 2025-11-13 | 6.53K shares 10-Q · filed 2025-11-13 | 78.31M shares 10-Q · filed 2024-11-14 | -48.24M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 49.23K shares 10-Q · filed 2025-08-14 | 73.85M shares 10-Q · filed 2024-08-12 | 49.23K shares 10-Q · filed 2025-08-14 | 73.84M shares 10-Q · filed 2024-08-12 | -64.32M shares derived: average of 3 quarters · filed 2025-08-14 | -31.71M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 738.29K shares 10-Q/A · filed 2025-08-14 | 73.83M shares 10-Q · filed 2024-05-14 | -96.50M shares derived: average of 2 quarters · filed 2025-08-14 | -42.29M shares derived: average of 3 quarters · filed 2025-08-14 | -15.26M shares derived: average of 4 quarters · filed 2025-08-14 | |||
| 2023-12-31 | -193.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -63.81M shares derived: average of 2 quarters · filed 2025-03-28 | -20.60M shares derived: average of 3 quarters · filed 2025-03-28 | 678.94K shares 10-K · filed 2025-03-28 | 67.89M shares 10-K · filed 2024-04-16 | |||
| 2023-09-30 | 66.13M shares 10-Q · filed 2024-11-14 | 66.13M shares 10-Q · filed 2023-11-20 | 65.98M shares derived: average of 2 quarters · filed 2024-11-14 | 65.49M shares 10-Q · filed 2024-11-14 | 62.36M shares derived: average of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | 65.83M shares 10-Q/A · filed 2024-11-14 | 65.43M shares 10-Q/A · filed 2024-11-14 | 61.10M shares derived: average of 3 quarters · filed 2024-11-14 | 53.90M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-03-31 | 64.63M shares 10-Q/A · filed 2024-11-14 | 58.74M shares derived: average of 2 quarters · filed 2024-11-14 | 49.93M shares derived: average of 3 quarters · filed 2024-11-14 | |||||
| 2022-12-31 | 52.85M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | 42.58M shares derived: average of 2 quarters · filed 2024-04-16 | 37.45M shares 10-K · filed 2024-04-16 | |||||
| 2022-09-30 | 32.31M shares 10-Q/A · filed 2023-11-21 | 32.31M shares 10-Q/A · filed 2023-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |